chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a severe sarcoidosis attack Sept-October. I am taking methotrexate 5 mg for that. I had the first  vaccine 12/30/20. 3 weeks later had a bump on the left leg. second dose 1/29/21. within a week there  was a sarcoid rash on the right leg (3x4 inches). My chronic cough increased mid January, and became  uncontrollable through March first. There was the stomatitis as well. I also had arthritis flareup in the  hip and finger. All began to improve March 2, 2021.
Experienced  outbreak of erythematous vesicles, ruested lesions. On abdomen, back face, legs , 50 lesions.
A few days after vaccination, I started getting hives and itching. I scratched so much I bruised my skin. Ended up at my primary care office. She prescribed Hydroxyzine  (25 mgs) and prescription Pepcid. She advised me to take Benadryl every 4-6 hours as well. Did that for a few days but nothing was getting better. I ended up at urgent care. Urgent care administered intramuscular injection of steroids and prescribed steroids. They also prescribed an epipen. Had referrals to endocrinology and dermatology after consulting with my doctors office again. Endocrinology didn?t have much to offer. Tests that need to be completed after I have been off of steroids for at least 2 weeks and any vitamins I was taking. Dermatology put me on 70 mgs of prednisone and taper down. Steroids were extended. Started having problems breathing as well. Started taking my albuterol inhaler. Dermatology prescribed Fexofenadine 360 mgs daily, hydroxizine 25 mgs every 6-8 hours, Pepcid morning and night, Zyrtec 4 per day.  I still have hives and I am off of the steroids as of right now. I am still on the rest. Everyone has scratched their heads on this; I have the same lotions, soaps, detergents, the only thing that has changed is the fact that received my 4th vaccine and prior I had Pfizer and this time I had moderna that is the only thing that has changed. I wanted this reported
developed worsening erythema and bullous lesions in right deltoid area. Erythema began on 8/1, bullae developed by 8/2, worsened on 8/3.
Information has been received from an investigator concerning a 3 month old female who was vaccinated with a first dose of ROTATEQ.  This report was part of a post-marketing surveillance study.  The infant (33 week twin) with 4 days of diarrhea and bloodystool and vomiting for 1 day referred to emergency department to rule out intussusception.  The patient was hospitalized on 30-SEP-2007.  Diagnosis confirmed by first air contrast enema, second air contrast enema successfully reduced ileocolic intussusception.  The patient was discharged home.  Event was 53 days post dose 1 of ROTATEQ.  Intussusception was determined to be an other important medical event.  No further information is available.
pt recvd vax; 8 hrs later felt achy & exp n, v, fever & d;sxs resolved in 10 days;reporter verifies the lot # & expiration date originally given;
Loss of consciousness (syncope) with urinary incontinence - occurred while standing - few minutes after HPV vaccinations. Regained consciousness about 1-2 minutes later when placed supine. Pt was diaphoretic and complained of feeling dizzy, sweaty and nauseous. Pt was observed for greater or equal 15 minutes. Orthostatics (P & BP) taken; drank water & was w/out clear Postictal signs.
p/vax pt exp arthus phenomenon on a total of four occasions p/both lymerix doses respectively;tics were on for a short period of time (1-4 hours) producing this phenomenon;pt exp erythema migrans;pt condition outcome unk; Case, reference number 1999013677-1, is a spontaneous report from a 66 year old male physician/consumer and a physician. Allergic to penicillin. No medical history, or concomitant medications. No illness at the time of vaccination. On unspecified dates, the patient received the first and second IM-left deltoid doses of LYMERIX for prevention of Lyme disease. The patient experienced possible Arthus phenomenon on a total of four occasions within a few hours after both LYMERIX doses, respectively. Tics were on for a short period of time (1-6 hours) producing this phenomenon. A long lasting reaction (local reaction weeks up to more than one month at injection site) was experienced. The patient developed a localized area of induration without fever, chills, or arthritis. He also experienced erythema migrans, and intense itching. Patient stated that he had imperfect protection with LYMERIX. The physcian/consumer attributed this reaction to LYMERIX but when it was pointed out that the chance of being bitten by four infected ticks at the same time was extremely small, he realized that this was not probable, and concluded that these were local reactions to a tick bite possibly due to a reaction to tick saliva but probably not true Arthus reactions and not related to LYMERIX. The patient's physician stated that symptoms had an incomplete resolution. There is still itching at the sites. The most recent information, received on 10-Nov-99, reports the outcome of the patient as ongoing.
This was the patients 3 rd pregnancy. At 8 weeks ultra sound the baby was healthy with a strong HR. Patient received the moderna boost vaccine on Jan 26th 2022. Subsequently, Patient was notified March 3rd that she had a miscarriage.
Decreased ROM, Constant burning and aching in left arm joints. Sharp pain when using arm at all. Extreme shoulder pain constantly.
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 02/02/2021 and 03/02/2021. They tested positive for COVID-19 on 09/19/2021.  They presented to emergency department and were admitted to hospital on 09/21/2021. Two repeat COVID-19 tests was also positive on 09/21/2021. Primary complaints for hospital admission were increased agitation, decreased appetite, and general weakness. On second day of hospitalization, the individual stopped all oral intake. The family agreed to comfort care only. The individual remained hospitalized until their death on 09/26/2021. They were diagnosed with failure to thrive in an adult and hypokalemia.
Moderna arm, rash , pain and swelling to injection site. Rash to forehead, rash noted to pallet inside of mouth (roof of mouth)
About 3 hours after injection,patient noticed a red, circular area at the site of the injection.  The red area increased in size to larger than a quarter but smaller than a baseball. patient stated that the circular area is elevated, warm to the touch, and itchy. patient has only tried warm packs and this was not effective.  patient stated that she also worked out later that day - run and abdominal work.  After the abdominal work, patient noticed a racing heart rate, dizziness, and chest pain that radiated down her left arm that went away after less than 5 minutes. patient stated that she works out often and has never had this type of reaction before.
Pt recv vax on 8/27/98; post vax pt exp LA weak, pain & flu-like sx
mom states pt started screaming & cried for approx 3 hrs cont-MD was notified of pt's react also called clinic & talked w/nurse;
Small itch bumps that turn into welts 9 days after vaccination. New welts are still forming. Rash on face stomach and legs.
Within two weeks of having my final dose, I developed an acute onset of diverticulitis which required Emergency visit to the doctor, CBC panel, X-ray at the doctors office, CT scan with contrast and high dose regimen of antibiotics. Additionally, developed three pilonidal cysts from 11/13 to 12/31 with antibiotics for treatment.
Exactly one week later, I had hives all over my body for 4 days.  I went to the doctors on the fourth day and said everything was fine. I took Benadryl.
Patient felt itchy and hot. Patient states that she had the same reaction when she received the flu vaccine. Patient premedicated with Diphentydramine prior to coming to the clinic. No actions were taken. no rash or breathing issues noted. Pateint observed for 30 minutes.
Information has been received from a medical technician concerning an 82 year old postmenopausal female with hypertension and no allergies who on 03-MAY-2007 was vaccinated with a dose of Zostavax (lot # 656606/0033U). There was no illness at the time of vaccination. On approximately 05-MAY-2007, the patient experienced ear pain. The patient went to the urgent care clinic and was prescribed acyclovir although a diagnosis of shingles was not reported by the patient. The patient was currently recovering. Medical attention was sought. No product quality complaint was involved. Additional information has been received from the medical technician who reported that on 05-MAY-2007, the patient developed an ear ache and two days later was seen at an urgent care clinic where she was placed on oral ZOVIRAX 800 mg QID x 10 days. The patient recovered on 10-MAY-2007. The patient had no adverse events following prior vaccination. Medical records from the patient's experience indicated that the patient was seen in urgent care on 05-MAY-2007. Her current medications were noted to be losartan potassium (MSD). She had taken two oxycodone the evening of 04-MAY-2007. Her chief complaint was an ear ache which started on 04-MAY-2007. She had extreme pain on the left  side in the ear, down the face and neck. The physician's impression was ear pain/early shingle. IN addition to ZOVIRAX she was prescribed oral PERCOCET 10/650 one Q4H prn. She was to follow up if there was a rash or if she was not better in two to three days. No further information is expected.
Patient reported experiencing numbness and tingling in left hand of the arm in which vaccine was administered, starting approximately 2 days after vaccine administration. There was redness and swelling extending to below the elbow in the left arm and itching extending down entire arm. Patient was seen at an urgent care facility and received a methylprednisolone dose pack 3 days after vaccination. Swelling and redness then reduced on days four and five following vaccination. Five days after administration, patient reported that the numbness and tingling was also being experienced in the right hand.
pt recv vax; localized redness, swelling, pain, fever, weakness in lt extremity; 5x7 cm;
Patient woke up in the middle of the night (night of the day the vaccine was given) and felt faint. Patient went out to kitchen to get something to eat and passed out. Went to couch for a couple of hours, tried to get up and felt as though she was going to pass out again. Patient was alone at the time. Patient said this feeling of being "faint" lasted about 2 weeks, each day getting slightly less.
Client reported "pressure in chest" 5 minutes after vaccination.  Assessed by onsite EMS:  B/P 129/80.  Client stated it's probably my nerves. Observed for 20 minutes.  Client stated, "I'm ok now."  Declined further monitoring. Encouraged to follow up with PCP or emergency services if needed.
Started with Rash/Hives on Neck and upper chest and shoulder.  Inside of nose rash and mouth itchiness.  Progressed to arms and palms of hands.  Started to get stomach upset.   mouth got warm and throat warm.  Breathing was OK but started to get tougher.  Went to the ED Given Benadryl Pepcid and solumedrol  Gave you prednisone 50mg  for home 3 tablets once a day and OTC pepcid
Patient vaccine injection was given. Upon immediate injection and plunger push the needle retracted immediately and less than 50% of vaccine was never injected into patient. Pharmacist Micah aware of situation and approved of a redose. Patient is aware of situation, is calm, and okay with a redose.
Information was received from a healthcare professional via GSK, concerning a male child, with no history of anaphylaxis, who on an unreported date(s) in 2007 was vaccinated with VARIVAX and HAVRIX. Immediately following the vaccination with VARIVAX and HAVRIX (lot # B206BA) the subject experienced an anaphylactic reaction. Adrenaline (Epinephrine) was administered and "the child was not admitted". At the time of reporting the outcome of the event was unspecified. The reporter was questioning the incidence of adverse reactions with this particular lot number of HAVRIX (lot # B206BA), or when given in combination with VARIVAX. The event of anaphylactic reaction was considered as a other medically important event (OME) by the reporter. Additional information is not expected.
Patient said they have been experiencing radiating pain at injection site through the muscle and under the skin since the night they got the injection.  They also received the high dose flu shot on the same day in the same arm but the patient has had the flu shot before with no reaction.
Acute rash , hives, pruritic ~ 3 hrs later.  Has history of progression to SOB/throat swelling  and ER care, so we gave Epipen Autoinjector and Benadryl 50 mg IM x1.  Vital signs stabilized after a BP drop. He clinically remained stable with improvement in itch/rash/hives.
Sudden onset of severe weakness in both legs 11 hours after vaccine was given. Could not walk.
sweating; I have a slight fever and I am nauseous; I have a slight fever and I am nauseous; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient reported that on unspecified date, they woke up on the 3rd morning after vaccine was administered sweating. They have a slight fever and was nauseous. The outcome of the events was unknown.  No follow-up attempts are possible. Information about Lot/Batch number cannot be obtained. No further information is expected
On April 28th I received my shot, within 2 days of that I started to break out in a rash down both arms and legs. A couple days later my breathing got more complicated. When I have my face mask on it's already hard to breath, but when I take my face mask off I still can't breath normally. The doc sent me for a CTA of my lungs on May 11th when they noticed I had multiple blood clots in my lungs. I ended up in the hospital on May 11th and started blood thinners the very next day. On or about the day of the vaccine, the rash started. The doctors put me on a dose pack and I had to stop taking my chemo for 3 days while on the steroid dose pack. The rash did go away by May 11th, but I still have the scabs from itching the rashes. On May 12th I started to get a sharp pain in my head that lasted for about a week. The doctors told me to get my 2nd shot. They wanted me to start the dose pack the morning of getting the 2nd shot in the afternoon.  That vaccine was three weeks to the date of my 1st vaccine. I didn't want to get the 2nd dose because of the reactions to the 1st dose, but I only got it to see my kids to get on a plane. The reaction after my second vaccine was a little worse. My arms got really itchy and my breathing got worse.
2:45 pm, swelling, redness and itching, like how my body reacts to a bee sting.    Hive like rash spread to chest and midsection around 9:00 pm
It was reported that a 37 year old female received Fluzone 98-99 sometime between 10/9/98 to 10/12/98. Reportedly sometime after the vax, the pt experienced systemic reactions of headache, general malaise, fever, nausea, and vomiting. From additional information received 11/3/98, it was reported that the pt also experienced diarrhea which lasted for 24 hours, and hoarseness and cough lasting for 5 days. The pt reportedly took Motrin for headache and soreness in throat.
I woke the next day after I had gotten the vaccine, it was around 12 hours later, my arm was hot to the touch and red and swollen. I had a fever and I felt very wiped out, it was very similar to the reaction that I had with my first vaccine. But in the this case it was much shorter lived I was better in 2 days.
Pharmaceutical product complaint; Only  liquid diluent portion of Menveo used; Only the liquid diluent administered; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 12-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA722Z, expiry date 31st August 2022) for prophylaxis. This case was associated with a product complaint.   On 29th September 2022, the patient received Menveo. On 29th September 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the inappropriate preparation of medication, inappropriate dose of vaccine administered and pharmaceutical product complaint were unknown.   Additional Information: GSK Receipt Date: 29-SEP-2022 Reporter's Comment: The reporter reporting a possible 7 patients having received only the liquid diluent portion of Menveo. The reporter consented to follow up. Additional Supportive Information: The reporter reporting a possible seven patients having received only the liquid diluent portion of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. This was 1 of 7 cases, reported by the same reporter.; Sender's Comments:  US-GSK-US2022140220:Same reporter- Patient 1 US-GSK-US2022140231:Same reporter- Patient 5 US-GSK-US2022140222:Same reporter- Patient 2 US-GSK-US2022140225:Same reporter- Patient 4 US-GSK-US2022140223:Same reporter- Patient 3 US-GSK-US2022140243:Same reporter- Patient 7
On September 3rd 2021 I received the COVID vaccine. By lunch time I was running a fever, had body aches, severe arm pain at injection site, numbness in my fingers and lips, fatigue, nerve pain along the scalp neck and face,  chills, dizziness when waking moving my neck or looking out of my peripheral vision. My fever broke Sunday morning. The body aches, severe pain at injection site and chills lasted until Wednesday September 8th. The numbness in fingers and lips lasted until Friday September 10th. The fatigue, nerve pain, dizziness upon moving, turning my head, or looking in my peripheral vision has lasted 10 days without relief.
Pt. states that after receiving the 3rd Booster of Moderna 10/28/2021, started experiencing symptoms 10/29/2021 of a heavy chest with rapid heart beat (lasting an hour). No noted Primary visit/communications. Symptoms have subsided.
Headache, fatigued, red and swelling of infection site, rash and itching at injection site.
Secondary insomnia. Every night since receiving vaccination I wake up between 4-5 AM.
Initial unsolicited report received from a pharmacist on 27-JUL-2016. This case involves a female patient (unknown age) who was vaccinated with a dose of ADACEL (batch number: U5292AA, expiration date: 14-Apr-2018, dose, dose in series were not  reported), intramuscularly in the right arm on 21-Apr-2016. The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient developed a knot at the injection site. Lab data and corrective treatment were not reported. The outcome for the event was reported as unknown. List of documents held by sender: none.
very sore arm at injection site as well as her left elbow; very sore arm at injection site; burning around her elbow; woke up to a very sore arm--at injection site as well as her left elbow; nerve pain; felt slightly nauseated; I was fatigued that night; This is a spontaneous report from a contactable consumer (patient). A 45-year-old female patient received the second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: ER8731), via an unspecified route of administration, administered in Arm Left on 27Apr2021 15:00 (received at 45-years-old) as 2ND DOSE, SINGLE for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccines. Medical history included hypothyroidism, arthritis, broken elbow 11 months ago (from 2020), and dairy sensitivity. She had no COVID prior vaccination and was not tested post vaccination. She was not pregnant. Concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (BNT162B2, Lot Number: EW0150), via an unspecified route of administration, administered in Arm Left on 06Apr2021 15:15 (received at 45-years-old) as 1ST DOSE, SINGLE for COVID-19 immunisation. The patient got her 2nd shot on 27Apr2021 and felt slightly nauseated at first. This went away. She was fatigued that night. The next morning, on 28Apr2021 07:00 AM, she woke up to a very sore arm at injection site as well as her left elbow (that she broke 11 months ago). She had dull aching pain, as well as burning around her elbow. She has been told that it's nerve pain. It is slowly getting better. As corrective treatment, the patient received Motrin, ice, and physical therapy. Outcome of the event was recovering.
Report described "feeling like he could not breathe" in a 20 year old male who received hep A vaccine. This report was received from a "consumer" and has not been verified by a physician or other health care professional. Allergies, medical history, and concomitant medications were not specified. On an unspecified date, the vaccinee received a dose of Havrix, it was not known whether he had received previous doses of Havrix. Subsequently, the vaccinee felt like he couldn't breathe. As of 06/04/2001, the outcome of the adverse event was unknown.
Pt presents to office 1 day after injection in (L) deltoid. 5.5 x 7 cm red, warm whelp at site. C/o soreness at site. No red streaking. No wheezing or facial swelling. I put TOPICORT ointment (steroid) on site. Drew a line around it so mom can call back if worse after treatment. Advised mom to give 2 tsp BENADRYL and MOTRIN every 6 hours. Ice the area the rest of afternoon.
03/12/2021 (beginning around 11 pm): fever, chills/bed sweats, severe headache, diarrhea 03/13/2021-3/14/2021: bed sweats at night, slight vaginal irritation progressively got more painful 03/15/2021: vagina has painful sores, red and swollen bumps burn and are painful, night sweats continue
Seen by Md for history of rash for 3 days, started on trunk and spread to neck and arms. Non fevers or other concerns noted. Patient recieved MMR vaccine two weeks ago. Md assessment rash most likely a reaction to MMR vaccine.
This case was reported by a pharmacist and described the occurrence of injection site pain in a male patient who received SHINGRIX. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain and adverse event. On an unknown date, the outcome of the injection site pain and adverse event were unknown. It was unknown if the reporter considered the injection site pain and adverse event to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The patient experienced local pain at the injection site and minimal constitutional symptoms. The patient said he was willing to have followed up from GlaxoSmithKline. This case has been linked with the case US2018GSK061148 and US2018GSK061147 and US2018GSK085969 reported by the same reporter.
About 29 hours after injection, experienced sudden chills, muscle fatigue, and coughing. Unable to fully sleep throughout the night. Chills and coughing faded by around 1am 1/30/21 (36 hours post-injection), but replaced by a headache. Took pain reliever around 5 am. By 9am 1/30/21 (44 hours post-injections), all adverse side effects cleared.
Day 10 post vaccine- rash at injection site (raised, red, itchy, and hot to touch) Day 1 post vaccine- achy, headache, malaise